Refresh

Glenmark Life Sciences Ltd. - Research Center

543322 GLS Group (A) BSE data
Back to Company

Results

Statement

More

Profit & Loss Account
(Rs crore)
Mar ' 24 Mar ' 23 Mar ' 22 Mar ' 21 Mar ' 20
Income

Operating income

2,283.21 2,161.22 2,123.21 1,885.17 1,537.31
Expenses

Material consumed

1,017.53 1,028.87 1,055.04 913.87 699.95

Manufacturing expenses

115.63 118.08 103.57 76.01 79.43

Personnel expenses

258.16 180.18 168.72 149.13 142.28

Selling expenses

- - - - -

Adminstrative expenses

217.65 191.80 179.82 155.08 143.70

Expenses capitalised

- - - - -

Cost of sales

1,608.97 1,518.93 1,507.15 1,294.09 1,065.35

Operating profit

674.25 642.29 616.06 591.07 471.96

Other recurring income

12.04 28.96 14.70 0.81 11.99

Adjusted PBDIT

686.29 671.25 630.76 591.89 483.95

Financial expenses

1.55 0.55 27.96 87.55 33.52

Depreciation

53.45 42.09 37.88 33.39 29.37

Other write offs

- - - - -

Adjusted PBT

631.29 628.61 564.93 470.94 421.07

Tax charges

160.40 161.65 146.20 119.36 107.97

Adjusted PAT

470.89 466.96 418.72 351.58 313.10

Non recurring items

-5.46 -0.29 0.10 -0.53 0.47

Other non cash adjustments

- - - - -

Reported net profit

465.43 466.67 418.82 351.06 313.57

Earnigs before appropriation

1,567.49 1,488.02 1,169.61 750.79 399.73

Equity dividend

275.69 385.96 128.65 - -

Preference dividend

- - - - -

Dividend tax

- - - - -

Retained earnings

1,291.80 1,102.06 1,040.95 750.79 399.73
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com